| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |